Follow the Eterna Therapeutics Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €16bn. The latest transaction was filed on 4 April 2025 (Acquisition). Among the most active insiders: Cherington Charles. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€2m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Eterna Therapeutics Inc. Strong Buy (bullish).
48Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 731 of 28,857 companies
82.9
score / 100
Value
92
Quality
74
FCF yld18%
Earn yld13%
EV/EBITDA4.8x
ROE21%
Gross mgn69%
Net mgn5.1%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.